Seventeen-millimeter St. Jude Medical Regent valve in patients with small aortic annulus: dose moderate prosthesis-patient mismatch matter?

Journal of Cardiothoracic Surgery - Tập 9 - Trang 1-9 - 2014
Jia Hu1, Hong Qian1, Ya-jiao Li2, Jun Gu1, Jing Janice Zhao1, Er-yong Zhang1
1Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China
2Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China

Tóm tắt

The study was designed to evaluate the effects of moderate prosthesis-patient mismatch (defined as 0.65 cm2/m2 < indexed effective orifice area ≤ 0.85 cm2/m2) on midterm outcomes after isolated aortic valve replacement with a 17-mm St. Jude Medical Regent valve in a large series of patients, and to determine if these effects are influenced by patient confounding variables. One-hundred and six patients with and without moderate prosthesis-patient mismatch early after implantation of a 17-mm Regent valve at aortic position were included. Both clinical and echocardiographic assessments were performed preoperatively, at discharge and during follow-up period (mean follow-up time 52.6 ± 11.9 months). The prevalence of moderate prosthesis-patient mismatch was documented in 46 patients (43.4%) at discharge. During the follow-up period, no difference in the regression of left ventricular mass, decrease of transvalvular pressure gradients, mortality and prosthesis-related complications was observed between patients with and without moderate prosthesis-patient mismatch. After adjustment for several risk factors, moderate prosthesis-patient mismatch was associated with increased midterm mortality in patients with baseline left ventricular ejection fraction < 50% (HR: 1.80, p = 0.02), but with normal prognosis in those with preserved LV function. Younger age (cut off value = 65 years) was not an independent predictor of increased midterm mortality and valve-related complications in patients with moderate prosthesis-patient mismatch. Moderate prosthesis-patient mismatch after aortic valve replacement with a small mechanical prosthesis is associated with increased mortality and adverse events in patients with pre-existing left ventricular dysfunction. Selected patients with small aortic annulus can experience satisfactory clinical improvements and midterm survival after aortic valve replacement with a 17-mm Regent valve.

Tài liệu tham khảo

Mizoguchi H, Sakaki M, Inoue K, Iwata T, Tei K, Miura T: Mid-term results of small-sized St. Jude Medical Regent prosthetic valves (21 mm or less) for small aortic annulus. Heart Vessels. doi:10.1007/s00380-012-0306-x Okamura H, Yamaguchi A, Nagano H, Itoh S, Morita H, Naito K, Yuri K, Adachi H: Mid-term outcomes after aortic valve replacement with the 17-mm St. Jude Medical Regent valve. Circ J. 2012, 76: 365-371. 10.1253/circj.CJ-11-0733. Coutinho GF, Correia PM, Paupério G, De Oliveira F, Antunes MJ: Aortic root enlargement does not increase the surgical risk and short-term patient outcome?. Eur J Cardiothorac Surg. 2011, 40: 441-447. Kulik A, Al-Saigh M, Chan V, Masters RG, Bédard P, Lam BK, Rubens FD, Hendry PJ, Mesana TG, Ruel M: Enlargement of the small aortic root during aortic valve replacement: is there a benefit?. Ann Thorac Surg. 2008, 85: 94-100. 10.1016/j.athoracsur.2007.07.058. Bleiziffer S, Ali A, Hettich IM, Akdere D, Laubender RP, Ruzicka D, Boehm J, Lange R, Eichinger W: Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement. Heart. 2010, 96: 865-871. 10.1136/hrt.2009.177220. Head SJ, Mokhles MM, Osnabrugge RL, Pibarot P, Mack MJ, Takkenberg JJ, Bogers AJ, Kappetein AP: The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J. 2012, 33: 1518-1529. 10.1093/eurheartj/ehs003. Hong S, Yi G, Youn YN, Lee S, Yoo KJ, Chang BC: Effect of the prosthesis-patient mismatch on long-term clinical outcomes after isolated aortic valve replacement for aortic stenosis: a prospective observational study. J Thorac Cardiovasc Surg. doi:10.1016/j.jtcvs.2012.07.101 Daneshvar SA, Rahimtoola SH: Valve prosthesis-patient mismatch (VP-PM): a long-term perspective. J Am Coll Cardiol. 2012, 60: 1123-1135. 10.1016/j.jacc.2012.05.035. Takaseya T, Kawara T, Tokunaga S, Kohno M, Oishi Y, Morita S: Aortic valve replacement with 17-mm St. Jude Medical prostheses for a small aortic root in elderly patients. Ann Thorac Surg. 2007, 83: 2050-2053. 10.1016/j.athoracsur.2007.01.044. Okamura H, Yamaguchi A, Tanaka M, Naito K, Kimura N, Kimura C, Kobinata T, Ino T, Adachi H: The 17-mm St. Jude Medical Regent valve is a valid option for patients with a small aortic annulus. Ann Thorac Surg. 2009, 87: 90-94. 10.1016/j.athoracsur.2008.09.051. Okamura H, Yamaguchi A, Noguchi K, Naito K, Yuri K, Adachi H: Hemodynamics and outcomes of aortic valve replacement with a 17- or 19-mm valve. Asian Cardiovasc Thorac Ann. 2010, 18: 450-455. 10.1177/0218492310381174. Mohty D, Dumesnil JG, Echahidi N, Mathieu P, Dagenais F, Voisine P, Pibarot P: Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction. J Am Coll Cardiol. 2009, 53: 39-47. 10.1016/j.jacc.2008.09.022. Jamieson WR, Ye J, Higgins J, Cheung A, Fradet GJ, Skarsgard P, Germann E, Chan F, Lichtenstein SV: Effect of prosthesis-patient mismatch on long-term survival with aortic valve replacement: assessment to 15 years. Ann Thorac Surg. 2010, 89: 51-58. 10.1016/j.athoracsur.2009.08.070. Mannacio V, Di Tommaso L, Stassano P, De Amicis V, Vosa C: Myocardial metabolism and diastolic function after aortic valve replacement for aortic stenosis: influence of patient-prosthesis mismatch. Eur J Cardiothorac Surg. 2012, 41: 316-321. 10.1016/j.ejcts.2011.05.039. Mohty D, Malouf JF, Girard SE, Schaff HV, Grill DE, Enriquez-Sarano ME, Miller FA: Impact of prosthesis-patient mismatch on long-term survival in patients with small St Jude Medical mechanical prostheses in the aortic position. Circulation. 2006, 113: 420-426. 10.1161/CIRCULATIONAHA.105.546754. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016/j.echo.2005.10.005. Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW: STS; AATS; EACTS. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg. 2008, 85: 1490-1495. 10.1016/j.athoracsur.2007.12.082. Minardi G, Manzara C, Creazzo V, Maselli D, Casali G, Pulignano G, Musumeci F: Evaluation of 17-mm St. Jude Medical Regent prosthetic aortic heart valves by rest and dobutamine stress echocardiography. J Cardiothorac Surg. 2006, 1: 27-10.1186/1749-8090-1-27. Amarelli C, Della Corte A, Romano G, Iasevoli G, Dialetto G, De Santo LS, De Feo M, Torella M, Scardone M, Cotrufo M: Left ventricular mass regression after aortic valve replacement with 17-mm St Jude Medical mechanical prostheses in isolated aortic stenosis. J Thorac Cardiovasc Surg. 2005, 129: 512-517. 10.1016/j.jtcvs.2004.07.007. Garatti A, Mori F, Innocente F, Canziani A, Gagliardotto P, Mossuto E, Santoro T, Montericcio V, Frigiola A, Menicanti L: Aortic valve replacement with 17-mm mechanical prostheses: is patient-prosthesis mismatch a relevant phenomenon?. Ann Thorac Surg. 2011, 91: 71-77. 10.1016/j.athoracsur.2010.08.036. Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B: Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation. 2010, 121: 2123-2129. 10.1161/CIRCULATIONAHA.109.901272. Brennan JM, Edwards FH, Zhao Y, O’Brien S, Booth ME, Dokholyan RS, Douglas PS, Peterson ED: DEcIDE AVR (Developing Evidence to Inform Decisions about Effectiveness–Aortic Valve Replacement) Research Team. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation. 2013, 127 (16): 1647-1655. 10.1161/CIRCULATIONAHA.113.002003. Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH: American College of Chest Physicians. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012, 141 (2 Suppl): e576S-600S. Han QQ, Xu ZY, Zhang BR, Zou LJ, Hao JH, Huang SD: Primary triple valve surgery for advanced rheumatic heart disease in Mainland China: a single-center experience with 871 clinical cases. Eur J Cardiothorac Surg. 2007, 31: 845-850. 10.1016/j.ejcts.2007.02.005. Fu B, Chen H, Dong L: Antithrombotic and thrombolytic therapy for valvular disease: can this guideline apply to Chinese?. Chest. 2013, 143 (5): 1513-1514. 10.1378/chest.12-3077. Pibarot P, Dumesnil JG: Valve prosthesis-patient mismatch, 1978 to 2011: from original concept to compelling evidence. J Am Coll Cardiol. 2012, 60: 1136-1139. 10.1016/j.jacc.2012.07.005.